Sponsors & CROsForCare Clinical Research (FCR) is dedicated to the advancement of treatments and reducing the time required to bring these to our community. This is accomplished through the execution of phase I through phase IV clinical research trials. ForCare is a consistent leader in enrollment, providing clean, timely data with engaged, certified Investigators and clinical trial staff. ForCare Clinical Research is driven to provide our clients with the highest quality service through all aspects of the clinical trial process. Our commitment is based on the following principles.
Honest Protocol Feasibility
ForCare performs an internal feasibility review that includes protocol analysis, patient population, trial logistics, and study design to direct identification and selection of trials where expectations are met or exceeded. We understand the importance of the feasibility process at both the Site and the Sponsor level and remain focused on fostering a partnership between our Site and our Sponsors.
Proven Recruitment & Outreach EffortsOur teams work together to develop pre-screening and recruitment strategies to target the population, decrease enrollment obstacles, and lessen the enrollment time. Efforts are made to identify the most productive and cost-effective method specific to the indication, and a recruitment plan is created. The recruitment plan is continually reviewed throughout the trial, and adjustments are made as needed.
We understand the necessity to shorten the trial start-up time at the clinical site. ForCare has streamlined its processes to meet the ever-increasing demands of enrollment readiness and prompt subject screening timelines with in-house staff completing regulatory submissions, contract and budget negotiations, training, and trial logistics in a collaborative and systematic manner.
Strategic Project ManagementTrial execution and logistics are coordinated by experienced management involved in all aspects of the clinical trial. This involves working directly with the Investigator and staff to ensure efficient start-up, QA/QC plans, and recruitment/outreach proposals in a productive manner while acting as a direct liaison to the Sponsor and/or CRO.
Quality ManagementThe multi-faceted quality management program is designed to shorten data entry timelines and decrease queries while remaining focused on protocol compliance and subject safety.
Seth B. Forman, MD
Medical Director and Principal Investigator, Seth B. Forman, M.D., is a board-certified dermatologist active in both private practice and clinical research. Dr. Forman is the lead Principal Investigator with a focus on innovative, therapeutic treatments. This has led not only into clinical research, but also into completion and publication of peer review articles and chapters. Clinical research is an integral part of his active private practice which provides him an opportunity to offer alternatives to his own patients and to have a personal involvement in potential treatments for difficult-to-treat populations.
Priya Ramani, MDPriya Ramani, MD is a practicing Rheumatologist. Dr. Ramani graduated from Jawaharlal Institute of Postgraduate Medical Education & Research in 1994 and has been in practice for 19 years. She completed a residency at St Lukes Roosevelt Hospital Center. Dr. Ramani also specializes in Internal Medicine. Dr. Ramani accepts multiple insurance plans including Aetna, SIHO Insurance Services and Medicare. In addition to English, Dr. Ramani’s practice supports this language: Spanish.
Clinical Trial MetricsPhase Subjects Contracted Subjects Randomized
Acne – 3 | 10 | 15
Actinic Keratosis – 2 | 15 | 29
Actinic Keratosis – 4 | 55 | 69
Actinic Keratosis – 2 | 12 | 23
Actinic Keratosis – 2 | 10 | 25
Alopecia Areata – 2 | 3 | 3
Atopic Dermatitis – 2 | 10 | 19
Atopic Dermatitis – 1 | 3 | 12
Atopic Dermatitis – 4 | 25 | 25
Atopic Dermatitis – 2 | 5 | 5
Atopic Dermatitis – 2 | 8 | 14
Atopic Dermatitis – 3 | 15 | 24
Atopic Dermatitis – 2 | 8 | 16
Atopic Dermatitis – 3 | 12 | 30
Hidradenitis Suppurativa – 3 | 10 | 26
Hidradenitis Suppurativa – 2 | 5 | 22
Hidradenitis Suppurativa – 2 | 5 | 10
Hidradenitis Suppurativa – 2 | 8 | 20
Psoriatic Arthritis – 2 | 4 | 20
Plaque Psoriasis – 2 | 5 | 13
Plaque Psoriasis – 2 | 10 | 35
Plaque Psoriasis – 3 | 10 | 16
Plaque Psoriasis – 3 | 12 | 21
Plaque Psoriasis – 3 | 12 | 23
Plaque Psoriasis – 2 | 5 | 13